Literature DB >> 2469697

In vitro differentiation of human-derived Pneumocystis carinii.

W Blumenfeld1, J M Griffiss.   

Abstract

Two major impediments to the development of an in vitro cultivation system for Pneumocystis carinii are lack of an accurate means of quantitation and difficulty in determination of viability over time. Human-derived P. carinii exists as aggregates of cysts and trophozoites in bronchoalveolar lavage fluid. These aggregates persisted over time in an in vitro system consisting of a monolayer of radiated or nonradiated A549 cells, RPMI 1640, and 10% fetal calf serum. Parallel measurements at specified times after introduction into the in vitro system of the number of aggregates, total aggregate area, and total number of cysts varied and appeared to be a function of the number of aggregates initially added into the system. However, cyst density, the number of cysts per unit aggregate area, was independent of the total number of aggregates added into the system. Cyst density was determined by staining an aggregate with a cyst-specific stain, such as toluidine blue, and counterstaining with Diff-Quik, allowing simultaneous visualization of cysts and aggregate area. Preliminary experiments suggested an increase in cyst density over time. Cyst density may be a means of accurate in vitro quantitation of P. carinii.

Entities:  

Mesh:

Year:  1989        PMID: 2469697      PMCID: PMC267343          DOI: 10.1128/jcm.27.3.480-485.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Propagation of Pneumocystis carinii in vitro.

Authors:  L L Pifer; W T Hughes; M J Murphy
Journal:  Pediatr Res       Date:  1977-04       Impact factor: 3.756

2.  Pneumocystis carinii: growth variables and estimates in the A549 and WI-38 VA13 human cell lines.

Authors:  M T Cushion; J J Ruffolo; M J Linke; P D Walzer
Journal:  Exp Parasitol       Date:  1985-08       Impact factor: 2.011

3.  Cultivation of Pneumocystis carinii with WI-38 cells.

Authors:  M S Bartlett; P A Verbanac; J W Smith
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

4.  Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.

Authors:  J A Kovacs; J W Hiemenz; A M Macher; D Stover; H W Murray; J Shelhamer; H C Lane; C Urmacher; C Honig; D L Longo
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

5.  Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.

Authors:  F M Gordin; G L Simon; C B Wofsy; J Mills
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

6.  Biological profile and response to anti-pneumocystis agents of Pneumocystis carinii in cell culture.

Authors:  L L Pifer; D D Pifer; D R Woods
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

7.  Growth and serial passage of Pneumocystis carinii in the A549 cell line.

Authors:  M T Cushion; P D Walzer
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

8.  Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; B L Smith
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

9.  Clinical features of Pneumocystis pneumonia in the acquired immune deficiency syndrome.

Authors:  L A Engelberg; C W Lerner; M L Tapper
Journal:  Am Rev Respir Dis       Date:  1984-10

10.  Pneumocystis carinii in sputum. Comparable efficacy of screening stains and determination of cyst density.

Authors:  W Blumenfeld; J M Griffiss
Journal:  Arch Pathol Lab Med       Date:  1988-08       Impact factor: 5.534

View more
  5 in total

1.  Quantification and assessment of viability of Pneumocystis carinii organisms by flow cytometry.

Authors:  S E Lapinsky; D Glencross; N G Car; J M Kallenbach; S Zwi
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

2.  A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes.

Authors:  J Shellito; V V Suzara; W Blumenfeld; J M Beck; H J Steger; T H Ermak
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

3.  Localization of host immunoglobulin G to the surface of Pneumocystis carinii.

Authors:  W Blumenfeld; R E Mandrell; G A Jarvis; J M Griffiss
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Purification of Pneumocystis carinii trophozoites and identification of their circulating antigens.

Authors:  T Ishimaru; N Shimono; Y Sawae; Y Niho
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 5.  Recent advances in diagnostic microbiology.

Authors:  Lulette Tricia C Bravo; Gary W Procop
Journal:  Semin Hematol       Date:  2009-07       Impact factor: 3.851

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.